comparemela.com
Home
Live Updates
Licensed Products - Breaking News
Pages:
14
15
16
17
18
19
20
Latest Breaking News On - Licensed products - Page 13 : comparemela.com
Form 8-K Moleculin Biotech, Inc For: Dec 20
Form 8-K Moleculin Biotech, Inc For: Dec 20
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
United states
Czech republic
Sao tome
Sao tome and principe
Papua new guinea
Saint lucia
Guinea bissau
Cook islands
United arab emirates
Costa rica
Cabo verde
Sierra leone
Harris county
Marshall islands
Trinidad and tobago
State of texas
iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products
Press release content from PR Newswire. The AP news staff was not involved in its creation.
United states
New york
Hong kong
Raj mehra
Geddy lee
X biopharma waferi
European medicines agency
Seelos therapeutics inc
Drug administration
Singapore exchange securities trading limited
Ix biopharma ltd
Seelos therapeutics inc nasdaq
Seelos therapeutics
Scientific advice
Complex regional pain syndrome
Licensed products
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Hong kong
New york
United states
Raj mehra
Geddy lee
Anthony marciano
Ix biopharma
Prnewswire seelos therapeutics inc
Seelos therapeutics inc
Drug administration
Exchange commission
Singapore exchange securities trading limited
Ix biopharma ltd
License agreement
Complex regional pain syndrome
Orphan drug
Seelos Therapeutics Announces Acquisition of an Exclusive License of iX Biopharma s Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine
/PRNewswire/ Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central.
Hong kong
New york
United states
Raj mehra
Geddy lee
Anthony marciano
Exchange commission
Ix biopharma
Seelos therapeutics inc
Drug administration
Singapore exchange securities trading limited
Ix biopharma ltd
Seelos therapeutics
License agreement
Complex regional pain syndrome
Orphan drug
iX Biopharma Signs Exclusive License Agreement For Wafermine And Other Sublingual Ketamine Wafer Products
/PRNewswire/ iX Biopharma Ltd (SGX:42C), a specialty pharmaceutical company that develops innovative therapies using its proprietary sublingual drug.
United states
New york
Hong kong
Raj mehra
Geddy lee
X biopharma waferi
European medicines agency
Seelos therapeutics inc
Drug administration
Singapore exchange securities trading limited
Ix biopharma ltd
Seelos therapeutics inc nasdaq
Seelos therapeutics
Scientific advice
Complex regional pain syndrome
Licensed products
vimarsana © 2020. All Rights Reserved.